维普中文期刊产品整合服务
21篇 您的检索式:作者名="Sullivan AW"
    题名 作者 年代 出处 被引量
1( +/- )-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors 显示文摘Sullivan JP Decker MW Brioni JD Donnelly-Roberts D Anderson DJ Bannon AW 1994J Pharmacol Exp Ther1994,271,:1
2NF-kappaB and p38 MARK inhibition improve survival in endotoxin shock and in a cecal ligation and puncture model of sepsis in combination with an- tibiotic therapy显示文摘O'Sullivan AW Wang JH Redmond HP 2009Surg Res2009,152,1:1
3Leukemic cell differentiation in vivo and in vitro: arrest of proliferation parallels the differentiation induced by the antileukemic drug Harringtonine 显示文摘Boyd AW Sullivan JR 1984Blood1984,63,2:1
4Neonatal exposure to genistein adversely impacts the ontogeny of hypothalamic kisspeptin signaling pathways and ovarian development in the peripubertal female rat显示文摘Losa SM Todd KL Sullivan AW 2011Reprod Toxico12011,31,3:1
5X-linked agammaglobulinemia: report on an untited states registry of 201 patients显示文摘Winkelstein JA Marino ML Lederman HM Jones SM Sullivan K Bruks AW 2006Medicine (Baltimore)2006,85,4:1
6Quality of life and HIV : current assessment tools and future directions for clinical practice 显示文摘Grossman HA Sullivan PS Wu AW 2003AIDS Read2003,13,:1
7The role of P38 MAPKand PKC in BLP induced TNF-alpha release,apoptosis,andNFkappa B activation in THP-1 monocyte cells显示文摘O’Sullivan AW Wang JH Redmond HP 2009J Surg Res2009,1,:1
8Leukemic cell differentiation in vivo and in vitro:Arrest of proliferation parallels the differentiation induced by the antileukemic drug harringtonine显示文摘Boyd AW Sullivan JR 1984Blood1984,6,:1
9Hypertonic saline enhances host response to bacterial challenge by augmenting receptor-independent neutrophil intracellular superoxide formation显示文摘Shields CJ O'Sullivan AW Wang JH 2003Ann Surg2003,238,2:1
10Risk factors for arm lymphedema following breast cancer diagnosis in black women and white women 显示文摘Meeske KA Sullivan - Halley J Smith AW 2009Breast Cancer Res Treat2009,113,:1
11Leukemie cell differentiation in vivo and in vitro:Arrest of proliferation parallels the differentiation induced by the antileukemic drug harringtonine 显示文摘Boyd AW Sullivan JR 1984Blood1984,63,2:1
12NF-kappaB and p38 MAPK inhibition improve survival in endotoxin shock and in a cecal ligation and puncture model of sepsis in combination with antibiotic therapy 显示文摘O'Sullivan AW Wang JH Redmond HP 2009J Surg Res2009,152,1:1
13Interleukin-6 is a potent growth factor for ER-α-positive human breast cancer显示文摘Sasser AK Sullivan N J Studebaker AW 0,,13:1
14Hypertonic saline enhanceshost response to bacterial challenge by augmenting receptor -independent neutrophil intracellular superoxide formation 显示文摘Shields C J O' Sullivan AW Wang JH 2003Ann Surg2003,238,2:1
15Leukemic cell differentiation in vivo and in vitro: arrest of proliferation parallels the differ- entiation induced by the antileukemic drug harringtonine 显示文摘Boyd AW Sullivan JR 1984Blood1984,63,2:1
16NF-kappaB and p38 MAPK inhibition improve survival in endotoxin shock and in a cecal ligation and puncture model of sepsis in combination with antibiotic therapy显示文摘O'Sullivan AW Wang JH Redmond HP 2009J Surg Res2009,152,1:1
17Nuclear factor kappa B (NF-κB) and p38 MAP kinase inhibition improves survival in endotoxin and polymicrobial models of sepsis显示文摘O'sullivan AW Wang JH Redmond HP 2002Shock2002,89,8:1
18The Adnectin CT-322 is a novel VEGF receptor 2 inhibitor that decreases tumor burden in an orthotopic mouse model of pancreatic cancer显示文摘Dineen SP Sullivan LA Beck AW 2008BMC Cancer2008,8,:1
19Risk factors for arm lymphedema following breast cancer diagnosis in black women and white women显示文摘Meesk KA Sullivan - Halley J Smith AW 2009Breast Cancer Res Treat2009,113,:1
20Interleukin-6 is a potent growth factor for ER-alpha-positive human breast cancer 显示文摘Sasser AK Sullivan NJ Studebaker AW et ol 2007FASEB J2007,21,13:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费